Alnylam Pharmaceuticals

RNA interference (RNAi) is a naturally occurring process of gene regulation that is already at work inside your body. RNAi therapeutics, which were pioneered by Alnylam, utilize this process to silence the genes that cause or contribute to disease. #ScienceCurious to learn more about #RNAi? Click here: https://bit.ly/3oR8r2l #RNAiTherapeutics #siRNA #GeneSilencing #RNA

Taking strides together in the fight against #Alzheimers disease! 💜 Alnylamites recently participated in the #Walk2EndAlz. Along with colleagues around the world, they proudly raised funds in support of the Alzheimer's Association® and its mission to provide education and support to the millions of people impacted by dementia and support research to finally #ENDALZ.

We've reported Q3 2024 financial results and highlights of recent period activity. Join us LIVE TODAY at 8:30 AM ET to hear from our leadership and/or access the replay later today at: https://bit.ly/374c75E. Read the Q3 2024 financial results press release: https://bit.ly/3YvCM8p #RNAi #RNAiTherapeutics #siRNA

Our message to the #amyloidosis community: We’re with you! In honor of #WorldAmyloidosisDay, Alnylam colleagues from across the globe came together to “Be the Link” and share heartfelt words of encouragement for those living with or caring for someone with amyloidosis. A big thank you to everyone who joined us! Together, we’re paving the way to a brighter future for the amyloidosis community.

We are thrilled to share that Arun Skaria has been appointed to the expanded role of Head of Diversity, Equity & Inclusion and Corporate Responsibility. At Alnylam, we believe that our long-term success and ability to deliver medicines to patients requires a diverse, equitable and inclusive workforce. Congratulations, Arun! #DiversityInclusion #DIversityEquityInclusion #CompanyCulture #CorporateResponsibility #CSR

We'll be sharing 3rd Quarter 2024 financial results this Thursday, 10/31 at 8:30 AM ET, during a LIVE webcast. Register here: https://bit.ly/374c75E and access the replay at the same link later in the day. #RNAi #RNAitherapeutics #siRNA

Healthcare Professionals: Do you have a patient presenting with severe, diffuse abdominal pain and seemingly unrelated symptoms? It could be acute hepatic #porphyria (AHP). Random (spot) urine tests are the primary method to help diagnose AHP and a genetic test can determine the type. Learn more about testing for AHP: https://bit.ly/2RCBrKF

On #WorldAmyloidosisDay, we proudly stand with Amyloidosis Alliance in support of the amyloidosis community. Although no two journeys are the same, every patient’s journey is linked through shared experiences and connections that remind us that no one faces this disease alone.

We're celebrating! 🎉 As a company driven by #science, it's important to us to be regarded by our peers as a great place for scientists to work. That's why we're so deeply honored to be named a Science Magazine and Science Careers Top Place to Work for 2024 - our 6th year in a row on this list! Thank you to all of our incredible employees whose contributions and passion make us a great place to work. Learn more and see the list: https://bit.ly/3Yo778y #SCTopEmployers #Biotechnology #Biotech #DrugDevelopment #PharmaCareers

Over 1000 colleagues from our global team, across 14 countries, dedicated their time for our annual Community Service Week, contributing to an impressive 48 projects. At Alnylam, we believe in making a positive impact on society beyond the innovative medicines we make, and nurturing a culture of service. After all, it’s more than just work, it’s our shared passion! #CommunityService #CSR #AlnylamProud